Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ACRV will decline by -5.06% over the next 2 Weeks and hit $1.48 by Monday, August 10, 2026. In that time frame, ACRV's share price is expected to range between $1.37 and $1.60.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 10, 2026 | 1.37 | 1.48 | 1.60 |
| Aug 7, 2026 | 1.42 | 1.52 | 1.64 |
| Aug 6, 2026 | 1.37 | 1.48 | 1.58 |
| Aug 5, 2026 | 1.40 | 1.50 | 1.62 |
| Aug 4, 2026 | 1.44 | 1.54 | 1.65 |
| Aug 3, 2026 | 1.41 | 1.52 | 1.63 |
| Jul 31, 2026 | 1.45 | 1.56 | 1.67 |
| Jul 30, 2026 | 1.41 | 1.52 | 1.62 |
| Jul 29, 2026 | 1.43 | 1.55 | 1.65 |
| Jul 28, 2026 | 1.48 | 1.58 | 1.70 |
ACRV shares fell -1.28% in Tuesday, July 28, 2026's trading session, dropping from a previous close of $1.56 to move at $1.54. The stock demonstrated notable intraday movement (see ACRV's key stats for a full breakdown), fluctuating between $1.51 and $1.54, a +1.99% trading range. While recent weeks have seen some volatility, ACRV has managed to secure a -27.70% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 149.46K shares changing hands, 108.34K fewer than the previous session. This amounted to $230.17K in total market activity.
Will ACRV Continue Its Upward Trend?
According to analyst ratings and projections for ACRV, Acrivon Therapeutics, Inc. Common Stock shares are anticipated to increase by +3.52%, potentially reaching $1.60 per share by August 10, 2026. Short-term technical indicators currently suggest a neutral sentiment for ACRV. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the ACRV stock forecast, now is a good time to buy ACRV stock because its current trading price is +3.98% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ACRV covering social and institutional perspectives.
ACRV Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ACRV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 29.93% to 41.74%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 46.79%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.47%, maintains a neutral outlook for the long term. Insights into ACRV's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Acrivon Therapeutics Common Stock Short-Term Forecasts
ACRV Forecast For Next 5 Days
Our algorithm anticipates Acrivon Therapeutics Common Stock (ACRV) stock could hit $1.58 by Aug 04, 2026. This represents a +2.85% rise from today's price, following a +20.25% change over the past five days.
ACRV Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Acrivon Therapeutics, Inc. Common Stock (ACRV) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $1.58, which would mean a +2.60% increase from the current price of $1.54. Projections for this period range from a high of $1.98 to a low of $1.23.
ACRV Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Acrivon Therapeutics Common Stock's price over the next three months point to a rise. ACRV stock is expected to peak at $4.71 on Aug 28, 2026 before potentially dipping to $3.22 on Oct 22, 2026. On average, ACRV is likely to trade around $4.15 in the coming 90 days.
Acrivon Therapeutics Common Stock Stock Forecast 2025
Based on our predictive models, Acrivon Therapeutics Common Stock (ACRV) is expected to trade between $1.09 and $4.71 throughout 2026. This would result in an average price of $4.02, potentially offering investors a +161.04% return from current levels.
Acrivon Therapeutics, Inc. Common Stock Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Acrivon Therapeutics, Inc. Common Stock (ACRV) is positioned to show a strong performance in July 2026. The price is predicted to move between $3.45 and $3.85, settling at an average of $3.66. This could translate to a +137.66% gain.
August 2026
Based on current market signals, Acrivon Therapeutics, Inc. Common Stock is projected to trend august 2026. We forecast a trading range from $3.46 to $4.71, with a likely average price of $4.03. Investors could expect a potential return of +161.69%.
September 2026
Our predictive algorithms indicate Acrivon Therapeutics, Inc. Common Stock stock may see a shift in September 2026. The expected range spans $3.57–$4.67, with an average target of $4.28. This represents a positive outlook and a possible gain of +177.92%.
October 2026
Analyzing established trends, Acrivon Therapeutics, Inc. Common Stock looks set to move in October 2026. Projections place the stock between $3.22 and $4.47, averaging around $4.25. This suggests a +175.97% gain from current levels.
November 2026
Market indicators suggest Acrivon Therapeutics, Inc. Common Stock could experience notable changes during November 2026. Prices could fluctuate within $2.02 to $4.65, with a midpoint forecast of $4.16. The stock might deliver a +170.13% gain.
December 2026
Forecasting for December 2026, models estimate that Acrivon Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $1.09 and $3.24, averaging $3.47. This signals a positive trajectory with potential returns around +125.32%.
January 2027
According to our latest forecast models, Acrivon Therapeutics, Inc. Common Stock (ACRV) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.14 and $2.79, settling at an average of $2.99. This could translate to a +94.16% gain.
February 2027
Based on current market signals, Acrivon Therapeutics, Inc. Common Stock is projected to trend february 2027. We forecast a trading range from $0.00 to $2.15, with a likely average price of $2.47. Investors could expect a potential return of +60.39%.
March 2027
Our predictive algorithms indicate Acrivon Therapeutics, Inc. Common Stock stock may see a shift in March 2027. The expected range spans $0.00–$2.49, with an average target of $3.32. This represents a positive outlook and a possible gain of +115.58%.
April 2027
Analyzing established trends, Acrivon Therapeutics, Inc. Common Stock looks set to move in April 2027. Projections place the stock between $0.00 and $2.46, averaging around $3.31. This suggests a +114.94% gain from current levels.
May 2027
Market indicators suggest Acrivon Therapeutics, Inc. Common Stock could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $2.27, with a midpoint forecast of $2.75. The stock might deliver a +78.57% gain.
June 2027
Forecasting for June 2027, models estimate that Acrivon Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.34, averaging $2.56. This signals a positive trajectory with potential returns around +66.23%.
July 2027
According to our latest forecast models, Acrivon Therapeutics, Inc. Common Stock (ACRV) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $3.21, settling at an average of $2.92. This could translate to a +89.61% gain.
ACRV's history of dividends and stock splits also plays a role in long-term investor confidence.